Consonance Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,309,206
| Closed | -$110M | – | 32 |
|
|
2019
Q1 | $110M | Buy |
3,309,206
+938,910
| +40% | +$31.2M | 6.94% | 5 |
|
|
2018
Q4 | $68.9M | Buy |
2,370,296
+723,966
| +44% | +$21M | 5.07% | 9 |
|
|
2018
Q3 | $75.7M | Buy |
+1,646,330
| New | +$75.7M | 4.08% | 11 |
|
|
2017
Q4 | – | Sell |
-1,973,177
| Closed | -$71.4M | – | 25 |
|
|
2017
Q3 | $71.4M | Sell |
1,973,177
-1,294,310
| -40% | -$46.8M | 7.9% | 6 |
|
|
2017
Q2 | $84.4M | Buy |
3,267,487
+291,131
| +10% | +$7.52M | 9.95% | 3 |
|
|
2017
Q1 | $57.1M | Buy |
2,976,356
+647,424
| +28% | +$12.4M | 5.99% | 7 |
|
|
2016
Q4 | $38.8M | Buy |
2,328,932
+1,478,932
| +174% | +$24.7M | 4.26% | 11 |
|
|
2016
Q3 | $17.5M | Buy |
+850,000
| New | +$17.5M | 1.68% | 15 |
|
|
2014
Q3 | – | Sell |
-507,682
| Closed | -$19.8M | – | 28 |
|
|
2014
Q2 | $19.8M | Sell |
507,682
-1,236,468
| -71% | -$48.1M | 2.94% | 15 |
|
|
2014
Q1 | $59.6M | Buy |
+1,744,150
| New | +$59.6M | 8.87% | 2 |
|